The cancer microenvironment influences malignant behaviors and treatment responses. Proprietary technology from Iscaffpharma can decode the microenvironment by focusing on patient-derived scaffolds, revealing important differences related to e.g. aggressiveness, age and subtypes of cancer. Iscaffpharma provides tools for drug discovery in the following areas: 1. drug screening 2. Target and drug discovery 3. Precision medicine (individualized treatment)
Iscaff Pharma
Iscaffpharma has deep understanding of the human tumor microenvironment and its role in creating aggressive cancer and use this knowledge to provide in-vivo like screening of drugs in human tumor models and synthetic replicas.
